期刊文献+

非透析慢性肾脏病患者发生肾性贫血风险预测模型的开发与验证 被引量:2

Development and validation of a risk prediction model for renal anemia in non-dialysis chronic kidney disease patients
下载PDF
导出
摘要 目的探讨非透析慢性肾脏病(CKD)患者发生肾性贫血的影响因素,建立非透析CKD患者发生肾性贫血的风险模型,并验证预测模型的有效性。方法回顾性分析2017年1月—2021年12月收治的非透析CKD患者的临床资料,按7∶3比例随机分为训练集(n=388)与验证集(n=165)。利用单因素和多因素Logistic回归分析筛选影响肾性贫血的影响因素,基于赤池信息准则(AIC)最小值选取最终预测因素构建列线图,并验证模型效能。结果单因素Logistic回归分析显示,17个变量[白细胞计数、中性粒细胞百分比、红细胞分布宽度(RDW)、血小板压积、碱性磷酸酶、血清白蛋白(ALB)、血胱抑素C、尿素、CKD分期、碳酸氢钠、血钾、血钙、血磷、C反应蛋白(CRP)、甘油三酯、尿白蛋白、尿隐血]与贫血的发生相关(P<0.05)。多因素Logistic回归分析结果提示,白细胞计数、CRP、RDW、ALB、血胱抑素C、尿素、CKD分期、碳酸氢盐、血钙是贫血独立影响因素(P<0.05)。利用危险因素构建列线图,经验证模型具有较好的区分度[训练集ROC曲线下面积(AUC)为0.915(95%CI:0.870~0.959),验证集为0.949(95%CI:0.927~0.971)]。校准曲线及H-L检验均提示模型预测值与实际值差异无统计学意义(P>0.05)。临床决策曲线分析(DCA)表明该模型具有良好的临床应用价值。结论本研究开发的预测模型能较好地预测非透析CKD患者肾性贫血的发生风险,为临床决策提供参考。 Objective To investigate the influencing factors of renal anemia in non-dialysis chronic kidney disease(CKD)patients,and to establish a risk model of renal anemia in non-dialysis CKD patients and verify its validity.Methods The clinical data of non-dialysis CKD patients admitted from January 2017 to December 2021 were retrospectively analyzed.The patients were randomly divided into training set(n=388)and validation set(n=165)at a ratio of 7∶3.Univariate and multivariate Logistic regression analysis was used to screen out the influencing factors for renal anemia.Based on the minimum Akaike Information Criterion(AIC)criterion,the final predictors were selected to construct the nomogram,and the efficiency of the model was verified.Results Multivariate Logistic regression analysis showed that 17 variables including white blood cell,percentage of neutrophil granulocyte,erythrocyte distribution width(RDW),thrombocytocrit,alkaline phosphatase,serum albumin(ALB),cystatin C,urea,CKD stage,bicarbonate,potassium,calcium,phosphorus,C-reactive protein(CRP),triglyceride,urinary albumin,occult urine were associated with anemia(P<0.05).Multiple Logistic regression analysis showed that white blood cell count,CRP,RDW,ALB,cystatin C,urea,CKD stage,bicarbonate and blood calcium were independent influencing factors for anemia(P<0.05).Using risk factors to construct a nomogram,the validation model had good discrimination[the area under ROC curve(AUC)of the training set was 0.915(95%CI,0.870 to 0.959),and the validation set was 0.949(95%CI,0.927 to 0.971)].The calibration curve and H-L test showed that there was no significant difference between the predicted value and the actual value of the model(P>0.05).The clinical decision curve analysis(DCA)showed that the model had good clinical application value.Conclusion The model developed in this study can better predict the risk of renal anemia in non-dialysis CKD patients,and provide reference for clinical decision-making.
作者 杨洁 边宇 张蕊 YANG Jie;BIAN Yu;ZHANG Rui(Department of Nephrology,the Second Hospital Affiliated to Harbin Medical University,Harbin,Heilongjiang,150001)
出处 《实用临床医药杂志》 CAS 2023年第10期72-78,共7页 Journal of Clinical Medicine in Practice
关键词 非透析慢性肾脏病 贫血 危险因素 预测模型 列线图 区分度 non-dialysis chronic renal disease anemia risk factors prediction model nomogram differentiation degree
  • 相关文献

参考文献5

二级参考文献26

  • 1吴兆龙,廖履坦,吴肇光,孙佩芳,蔡祝辉,蔡幼德,陶宗晋,程文英,沈维堂.尿毒症病人的血清中分子物质的生物活性[J].中国病理生理杂志,1995,11(1):90-94. 被引量:11
  • 2J.萨姆布鲁克 金东雁(译).分子克隆实验指南[M].北京:科技出版社,1996.19-23,42-56,330.
  • 3刘秀珍.造血干细胞培养技术[M].北京:北京出版社,1993.46.
  • 4Lacombe C, Mayeux P. Biology of erythropoietin[J].Haematologica, 1998, 83: 724.
  • 5Xiao ZS, Quarles LD, Chen QQ. et al. Effect of asymmetric dimethylarginine on osteoblastic differentiation[J].Kidney Int, 2001,60 : 1699.
  • 6Mun KC, Golper TA. Impaired biological activity of erythropoietin by cyanate carbamylation[J]. Blood Purif,2000,18:13.
  • 7Basile C, Giordano R, Montanaro, et al. Effect of acetate-free biofiltration on the anaemia of haemodialysis patients: a prospective cross-over study[J]. Nephrol Dial Transplant, 2001,16 : 1914.
  • 8Komatsuda A, Hirokawa M, Haseyama T, et al. Human parathyroid hormone does not influence human erythropoiesis in vitro[J]. Nephrol Dial Transplant, 1998,13:2088.
  • 9Chikao Y, Kenzo M, Taihei Y, et al. Early effects of parathyroidectomy on erythropoietin production in secondary hyperparathyroidism[J]. Am J Surg, 2002,183:199.
  • 10Mulcahy L. The erythropoietin receptor[J]. Semin Oncol, 2001, 28(2suppl 8): 19.

共引文献31

同被引文献20

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部